Kazia Therapeutics Limited
KZIA
$3.30
-$0.2395-6.77%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.92M | -5.90M | -2.88M | -2.89M | -2.30M |
| Total Depreciation and Amortization | 307.80K | 307.20K | 304.60K | 306.00K | 312.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.52M | 1.51M | 236.60K | 237.70K | -764.60K |
| Change in Net Operating Assets | 3.02M | 3.02M | 269.80K | 271.10K | 629.20K |
| Cash from Operations | -1.07M | -1.07M | -2.06M | -2.07M | -2.12M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -300.00 | -300.00 | 388.30K | 388.30K | -- |
| Total Debt Repaid | 400.00 | 400.00 | -185.90K | -185.90K | -- |
| Issuance of Common Stock | 644.00K | 644.00K | 2.33M | 2.33M | 3.76M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -27.90K | -27.90K | -160.40K | -160.40K | -200.40K |
| Cash from Financing | 406.00K | 405.20K | 1.55M | 1.56M | 2.38M |
| Foreign Exchange rate Adjustments | 35.70K | 35.60K | -31.40K | -31.60K | 26.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -627.80K | -626.50K | -547.00K | -549.60K | 284.10K |